Taxane-containing regimens for metastatic breast cancer-Reference-Cited by-同舟云学术

Taxane-containing regimens for metastatic breast cancer

Published:2015-06-10 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ghersi Davina¹,Willson Melina L²,Chan Matthew Ming Ki³⁴,Simes John⁵,Donoghue Emma⁶,Wilcken Nicholas⁷⁸

Affiliation:

1. National Health and Medical Research Council; Research Translation Group; 16 Marcus Clarke Street Canberra ACT Australia 2601

2. NHMRC Clinical Trials Centre, The University of Sydney; Systematic Reviews and Health Technology Assessments; Locked Bag 77 Sydney NSW Australia 1450

3. The Crown Princess Mary Cancer Centre Westmead, Westmead Hospital; Medical Oncology; Westmead New South Wales Australia 2145

4. Central Coast Cancer Centre, Gosford Hospital; Medical Oncology; Gosford NSW Australia 2250

5. The University of Sydney; NHMRC Clinical Trials Centre; Locked Bag 77 Camperdown NSW Australia 1450

6. The University of Melbourne; Melbourne Conservatorium of Music; Melbourne Victoria Australia 3004

7. Westmead and Nepean Hospitals; Medical Oncology; Department of Medical Oncology and Palliative Care Westmead Hospital Westmead NSW Australia 2145

8. The University of Sydney; Sydney Medical School; Sydney Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference133 articles.

1. Docetaxel versus doxorubicin in patients with metastatic breast cancer who have failed alkylating chemotherapy: a preliminary report of the randomized phase III trial. 303 Study Group;Aapro;Seminars in Oncology,1998

2. Docetaxel vs doxorubicin in metastatic breast cancer resistant to alkylating chemotherapy;Chan;Oncology (Huntington),1997

3. Chan S Friedrichs K Noel D Duarte R Vorobiof D Pinter T Docetaxel (Taxotere) vs doxorubicin in patients with metastatic breast cancer (MBC) who have failed alkylating chemotherapy. Randomized multicenter phase III trial Proceedings of American Society of Clinical Oncology; 1997 1997 Abstract 540

4. Chan S Friedrichs K Noel D Pinter T Van Belle S Vorobiof D A phase III study of taxotere vs doxorubicin in patients with metastatic breast cancer who have failed an alkylating containing regimen Breast Cancer Research and Treatment; San Antonio Breast Cancer Symposium; 1997; San Antonio 1997 Abstract 1 4776

5. Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. John Crown for the 303 Study Group;Chan;Journal of Clinical Oncology,1999

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time-Dependent Changes of Extremity Volume and Tissue Alterations in Swollen Arms Caused by Taxanes;Lymphatic Research and Biology;2024-04-02

2. Taxanes for the treatment of breast cancer during pregnancy: an international cohort study;JNCI: Journal of the National Cancer Institute;2023-12-07

3. Individual participant data from digital sources informed and improved precision in the evaluation of predictive biomarkers in Bayesian network meta-analysis;Journal of Clinical Epidemiology;2023-12

4. Relative dose intensity of taxane-based chemotherapy in breast cancer patients in a tertiary hospital;Journal of Oncology Pharmacy Practice;2023-11-15

5. Three-Week Versus 4-Week Schedule of nab-Paclitaxel in Patients With Metastatic Breast Cancer: A Randomized Phase II Study;The Oncologist;2023-10-26